UniProtKB/SwissProt variant VAR

Variant information

Variant position:

85

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:

Disease [Disclaimer]

The variants are classified into three categories: Disease, Polymorphism and Unclassified.

Disease: Variants implicated in disease according to literature reports.
Polymorphism: Variants not reported to be implicated in disease.
Unclassified: Variants with uncertain implication in disease according to literature reports. Evidence against or in favor of a pathogenic role is limited and/or conflicting.

Residue change:

From Arginine (R) to Tryptophan (W) at position 85 (R85W, p.Arg85Trp).

Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:

Change from large size and basic (R) to large size and aromatic (W)

The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:

-3

The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page

Involvement in disease:

Fanconi renotubular syndrome 4 with maturity-onset diabetes of the young (FRTS4) [MIM:616026]: A disease characterized by Fanconi syndrome associated with a beta cell phenotype of neonatal hyperinsulinism with macrosomia and young onset diabetes. Fanconi syndrome is a proximal tubulopathy resulting in generalised aminoaciduria, low molecular weight proteinuria, glycosuria, hyperphosphaturia and hypouricemia. Some FRTS4 patients have nephrocalcinosis, renal impairment, hypercalciuria with relative hypocalcemia, and hypermagnesemia. {ECO:0000269|PubMed:22802087, ECO:0000269|PubMed:24285859}. Note=The disease is caused by mutations affecting the gene represented in this entry.

The name and a short description of the disease associated with the variant. For more information about the disease, the user can refer to OMIM, following the link provided after the disease acronym.

Variant description:

In FRTS4.

Any additional useful information about the variant.

Other resources:

Links to websites of interest for the variant.

Variant rs587777732 [ dbSNP | Ensembl ]

Sequence information

Variant position:

85

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:

474

The length of the canonical sequence.

Location on the sequence:

DRATGKHYGASSCDGCKGFF R RSVRKNHMYSCRFSRQCVVD

The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         DRATGKHYGASSCDGCKGFFRRSVRKNHMYSCRFSRQCVVD

Mouse                         DRATGKHYGASSCDGCKGFFRRSVRKNHMYSCRFSRQCVVD

Rat                           DRATGKHYGASSCDGCKGFFRRSVRKNHMYSCRFSRQCVVD

Xenopus laevis                DRATGKHYGASSCDGCKGFFRRSVRKNHMYSCRFSRQCVVD

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 474	Hepatocyte nuclear factor 4-alpha
DNA binding	57 – 132	Nuclear receptor
Helix	78 – 89

Literature citations

Novel presentations of congenital hyperinsulinism due to mutations in the MODY genes: HNF1A and HNF4A.
Stanescu D.E.; Hughes N.; Kaplan B.; Stanley C.A.; De Leon D.D.;
J. Clin. Endocrinol. Metab. 97:E2026-2030(2012)
Cited for: INVOLVEMENT IN FRTS4; VARIANT FRTS4 TRP-85;

The HNF4A R76W mutation causes atypical dominant Fanconi syndrome in addition to a beta cell phenotype.
Hamilton A.J.; Bingham C.; McDonald T.J.; Cook P.R.; Caswell R.C.; Weedon M.N.; Oram R.A.; Shields B.M.; Shepherd M.; Inward C.D.; Hamilton-Shield J.P.; Kohlhase J.; Ellard S.; Hattersley A.T.;
J. Med. Genet. 51:165-169(2014)
Cited for: VARIANT FRTS4 TRP-85;

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P41235: Variant p.Arg85Trp